top of page
Recent Posts
See AllCHMP gave a positive opinion for treating BMS' cell-therapy Breyanzi for relapsed or refractory follicular lymphoma Bristol Myers Squibb...
The European Commission has granted approval for the use of Rybrevant ( amivantamab) in combination with Lazcluze ( lazertinib) as a...
The European Commission (EC) has approved Kisqali (ribociclib) in combination with aromatase inhibitors (AI) for the treatment of...
bottom of page
Commentaires